I-Mab Biopharma commences pivotal study of TJ202/MOR202 in China

China |  News | 0 Comment | 06 Jan, 2020

I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States and focused on the discovery and development of novel or highly differ...Read more

Leap, BeiGene to develop immunotherapy for gastric cancer

China |  News | 0 Comment | 06 Jan, 2020

US based Leap Therapeutics, Inc. a biotechnology company developing targeted immuno-oncology therapeutics, and China headquartered BeiGene, Ltd., a commercial-stage biopharmaceutical compan...Read more

WuXi STA opens oligonucleotide large-scale manufacturing facility

China |  News | 0 Comment | 03 Jan, 2020

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec  has announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) m...Read more

BeiGene completes acquisition deal with Amgen

China |  News | 0 Comment | 03 Jan, 2020

BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer has ann...Read more

Fountain Medical appoints Ling Zhen as Co-Chairman and CEO

China |  News | 0 Comment | 02 Jan, 2020

China based Fountain Medical Development Limited ("Fountain Medical" or "Company"), a clinical stage CRO dedicated to offering high-quality one-stop services to pharmaceutical and medical d...Read more

CF PharmTech to accelerate respiratory drugs development

China |  News | 0 Comment | 02 Jan, 2020

China based CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million ...Read more

China grants priority review to Luye Pharma's schizophrenia drug

China |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004), an innovative formulation independently developed ...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

China |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This ...Read more

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

China |  News | 0 Comment | 31 Dec, 2019

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences in San Francisco, California at the...Read more

China's Largest Plasmid and Virus Facility from GenScript in Operation

China |  News | 0 Comment | 20 Dec, 2019

The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation on December 18, 2019. It is a milest...Read more

Sinovac receives China's approval for varicella vaccine

China |  News | 0 Comment | 31 Dec, 2019

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medical Products Administration (NMPA) has approved and issued a Product li...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

China |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of m...Read more

Oncologie Selected as Top 100 Innovative Pharmaceutical Company in China

China |  News | 0 Comment | 30 Dec, 2019

Oncologie, a biopharmaceutical company with innovative oncology therapeutics supported by a biomarker platform to select patients, on 27 Dec 2019, announced that it has been selected as a T...Read more

Elpiscience secures $100M for expanding portfolio

China |  News | 0 Comment | 30 Dec, 2019

China based clinical-stage biopharmaceutical company focusing on cancer immunotherapy Elpiscience Biopharma has announced the completion of Series B financing of 100 million USD. The round...Read more

Shanghai to host bioLIVE China 2020

China |  News | 0 Comment | 27 Dec, 2019

To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry---bioLIVE China 2020, will b...Read more

Bonotox launches artificial veil cream in China

China |  News | 0 Comment | 26 Dec, 2019

BONOTOX, a South Korea based cosmeceutical company which launched the world's first ‘Artificial Veil Cream’, has announced that it will enter the Chinese market. BONOTOX is expe...Read more

Tracon announces partnership with 3D Medicines and Jiangsu Alphamab

China |  News | 0 Comment | 24 Dec, 2019

TRACON Pharmaceuticals, a US based clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, has announced that it...Read more

Hisky launches new brand iLivTouch

China |  News | 0 Comment | 23 Dec, 2019

Recently, China based Wuxi Hisky Medical Technologies Co., Ltd. has successfully launched its new brand iLivTouch based on the MigTE technology. "On the increasingly competitive market, cyc...Read more